Skip to main content

Table 2 Differential mRNA expression changes in healthy ASM cells after treatment with FCS or Dex + FCS

From: Role of non-coding RNAs in maintaining primary airway smooth muscle cells

mRNA

FCS

Dex + FCS

Microarray (FC)

qRT-PCR (FC)

Microarray (FC)

qRT-PCR (FC)

FAM71F1

−1.7 (<.05)

−1.62 (<.05)

1.7 (<.05)

1.56 (<.05)

METTL7A

−1.9 (<.01)

−0.85 (<.05)

2.1 (<.01)

5.77 (<.01)

PLSCR4

−1.5 (<.001)

−0.33 (<.05)

1.6 (<.001)

6.47 (<.001)

TUBB3

1.5 (<.05)

1.22 (<.05)

−1.7 (<.001)

−2.18 (<.05)

WDFY4

−1.8 (<.05)

−3.60 (<.01)

1.8 (<.05)

2.01 (<.05)

  1. This table lists those mRNAs that were differentially expressed in healthy ASM cells following stimulation with FCS (2.5%) or treatment with dexamethasone (10−7 M) before stimulation with FCS (2.5%). Microarray data are denoted as the fold change against baseline control and is the mean of 9 individual patients. These values are derived from Additional file 1: Table S1, S2, S3, S4 and are for those genes that demonstrated an FDR of less than 0.05; associated P values are shown in parentheses. FC, Fold change.